Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148992 · ClinicalTrials.gov registry record · Phase 1
Interactions Between Intravenous (IV) Cocaine and Lofexidine
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01148992 is a Phase 1 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 16 participants.
The verdict
NCT01148992, a Phase 1 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and treatment with lofexidine.
Interventions
- DRUG Placebo
- DRUG Lofexidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01148992
The ClinicalTrials.gov registry entry for NCT01148992 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01148992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01148992 about?
NCT01148992 is a clinical study titled "Interactions Between Intravenous (IV) Cocaine and Lofexidine". The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and treatment with lofexidine.
What is the current status of trial NCT01148992?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2010-08. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01148992?
The interventions under investigation include: Placebo (DRUG), Lofexidine (DRUG).
Who is sponsoring clinical trial NCT01148992?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.